Pantoprazole Does Not Reduce the Antiplatelet Effect of Clopidogrel: A Randomized Controlled Trial in Korea - Wikidata - awgldk - TriplyDB

Pantoprazole Does Not Reduce the Antiplatelet Effect of Clopidogrel: A Randomized Controlled Trial in Korea

Pantoprazole Does Not Reduce the Antiplatelet Effect of Clopidogrel: A Randomized Controlled Trial in Korea

http://www.wikidata.org/entity/Q33853179

about

Effects of different CYP2C19 genotypes on prognosis of patients complicated with atrial fibrillation taking clopidogrel after PCI

P2860

Q58718007-81669BAF-2976-4C4F-B0AC-65D33B6B2632

P2860

Pantoprazole Does Not Reduce the Antiplatelet Effect of Clopidogrel: A Randomized Controlled Trial in Korea

http://www.wikidata.org/entity/Q33853179

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Pantoprazole Does Not Reduce t ...... ized Controlled Trial in Korea

@ast

Pantoprazole Does Not Reduce t ...... ized Controlled Trial in Korea

@en

type

label

Pantoprazole Does Not Reduce t ...... ized Controlled Trial in Korea

@ast

Pantoprazole Does Not Reduce t ...... ized Controlled Trial in Korea

@en

prefLabel

Pantoprazole Does Not Reduce t ...... ized Controlled Trial in Korea

@ast

Pantoprazole Does Not Reduce t ...... ized Controlled Trial in Korea

@en

P1433

Q33853179-C94EDFDE-6328-4F89-91EC-A239EC6B91D4

P1476

Q33853179-10AD36AB-705E-4184-AE25-4A757E6181D0

P2093

Q33853179-06F47D08-8F2C-4B7B-B5FE-3A2E5BE92516

Q33853179-106E5F7D-87DD-4B69-A45E-66B356838D87

Q33853179-3D0E3F92-6B89-40AD-91E2-E8D89273A8D3

Q33853179-7229E581-3E00-467E-B35B-DD66081EF49F

Q33853179-84E29AE0-45D1-4C1F-AF3D-575DEEE38513

Q33853179-A19EFD2A-A688-4E6A-B8D6-CA119A30F712

Q33853179-AFFF0DE1-4E8B-40C6-ACC7-519DECCE1D47

Q33853179-D498B3D0-84C2-41EA-AB5D-EF89BF6CFD5E

Q33853179-DCDF34E8-7530-4499-B37F-B7E7B8DFB97B

Q33853179-DE7B808F-DB0F-422B-8604-060ABD65A6D4

P2860

Q33853179-00AF6636-742B-457C-A991-E69A39E9DFF5

Q33853179-07DF71D8-0DF9-4DA8-9DC3-BC0CECB18D56

Q33853179-1579D3DF-23F0-417F-A042-026754D66A96

Q33853179-169F4532-0052-4106-9610-D8C4DB75CD80

Q33853179-1C4D7268-CCC9-4C1E-9E5D-554E7CD237A3

Q33853179-1D470E40-E4DF-4E09-8939-FB1F819CB5DC

Q33853179-21BF8188-88E2-4F03-8264-D7A09A20D0E3

Q33853179-2C2AB4D8-A673-4DC7-9429-6F7499719D8F

Q33853179-41A516FB-A23D-4951-8D3F-D23F45FAD231

Q33853179-440F200D-73D9-4D6B-BEF8-12EEE9C17704

P304

Q33853179-2224A12A-00CA-4977-B847-FCCD5C28F15A

P31

Q33853179-636DF5B3-72CC-457B-81CF-9AE275C84013

P356

Q33853179-EC190E8F-0E44-48EC-8032-1866D6CE494F

P433

Q33853179-1EE6BD94-09F3-4E3E-8A96-83E3BB228823

P478

Q33853179-E70C8B8D-ACF1-4F82-AEC2-1497AD324ADB

P50

Q33853179-11D4181D-2702-44B6-A98C-4D5DE933B3A5

Q33853179-658CCE9F-7E27-40FD-8F64-EA2BC462D3CD

P577

Q33853179-431D2764-5C03-41AF-9686-BE42D9E3F0B8

P698

Q33853179-70059105-664A-4166-9FB2-3F5CA654133A

P921

Q33853179-BCF17259-D705-4A85-BA7B-B0400AE6A691

P932

Q33853179-C04D1079-A570-4A4F-BB69-AFC1C1370173

P356

P1433

P1476

Pantoprazole Does Not Reduce t ...... ized Controlled Trial in Korea

@en

P2093

Cheol Min Shin

http://www.w3.org/2001/XMLSchema#string

Dong Ho Lee

http://www.w3.org/2001/XMLSchema#string

Hyuk Yoon

http://www.w3.org/2001/XMLSchema#string

Hyun Chae Jung

http://www.w3.org/2001/XMLSchema#string

Hyun Jin Jo

http://www.w3.org/2001/XMLSchema#string

In-Jin Jang

http://www.w3.org/2001/XMLSchema#string

Ji Hyun Park

http://www.w3.org/2001/XMLSchema#string

Ryoung Hee Nam

http://www.w3.org/2001/XMLSchema#string

Yoon Jin Choi

http://www.w3.org/2001/XMLSchema#string

Young Soo Park

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor - Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific Region

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk?

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans

Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome

Review article: drug interactions with agents used to treat acid-related diseases.

Effect of Low-dose, Enteric Coated Aspirin on Gastrointestinal Bleeding in Patients with Coronary Artery Disease

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.

Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole.

P304

504-511

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5009/GNL16352

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28395507

http://www.w3.org/2001/XMLSchema#string

P921

P932

5491085

http://www.w3.org/2001/XMLSchema#string